January 1, 2003
View Full PaperSeries Introduction: Neurodegeneration: What is it and where are we?
Key Points
Key points are not available for this paper at this time.
Abstract
Alzheimer disease (AD); Parkinson disease (PD); Huntington disease (HD); amyotrophic lateral sclerosis (ALS); neurofibrillary tangle (NFT); superoxide dismutase-1 (SOD1); programmed cell death (PCD).